|

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

RECRUITINGN/ASponsored by Medtronic Cardiovascular
Actively Recruiting
PhaseN/A
SponsorMedtronic Cardiovascular
Started2026-09-11
Est. completion2031-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations13 sites

Summary

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years at the time of consent.
* Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT).
* Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR.

Exclusion Criteria:

* Any tricuspid device currently in place.
* Anatomic contraindications.
* Need for emergent or urgent surgery.
* Left ventricular ejection fraction \<25%.

Conditions2

Heart DiseaseSevere Tricuspid Regurgitation

Locations13 sites

University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama, 35233
Kathy Phillips205-975-1888kcphillips@uabmc.edu
Abrazo Arizona Heart Hospital
Jesica Byrne602-952-0002jessica.byrne@abrazohealth.com
Los Robles Hospital & Medical Center
Thousand Oaks, California, 91360
Jason Yashar805-796-5881jason.yashar@hcahealthcare.com
Yale New Haven Hospital
New Haven, Connecticut, 06510
Scott Ardito203-737-3570scott.ardito@yale.edu
Emory University Hospital Midtown
Maria Kaner404-313-6971maria.kaner@emory.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.